TMEM16A is upregulated in cystic fibrosis and asthma, which accompanies goblet cell metaplasia (in asthma) and goblet cell hyperplasia (in cystic fibrosis) and mucus hypersecretion [2,3]. Here, ANO1 is linked to cystic fibrosis.